Medicine and Dentistry
Cisplatin
91%
Carcinoma
91%
Esophagus
66%
Fluorouracil
66%
Recombinant Interferon
66%
Radiation Therapy
57%
Interferon
51%
Clinical Trial
48%
Amifostine
44%
Uterine Cervix
44%
Disease
40%
Malignant Neoplasm
37%
External Beam Radiotherapy
32%
Colorectal Carcinoma
31%
Squamous Cell
29%
Sargramostim
26%
Esophagus Carcinoma
26%
Gynecological Oncology
25%
Oncology
25%
Colorectal Cancer
24%
Adenocarcinoma
23%
Ras Signaling
22%
Advanced Cancer
22%
Brachytherapy
22%
Cancer Cell
22%
Hydroxyurea
22%
Embolization
22%
Head and Neck Cancer
22%
Oncolytic Adenovirus
22%
Supportive Care
22%
Cervix
22%
Transcatheter Arterial Chemoembolization
22%
Stomach Carcinoma
22%
Pelvis
22%
Cancer Recurrence
22%
Stereotactic Body Radiation Therapy
22%
Squamous Cell Carcinoma
20%
Phase II Trials
17%
Transverse Myelitis
14%
Diarrhea
14%
Metastatic Carcinoma
13%
Cervical Cancer
12%
Phase I Trials
12%
In Vitro
11%
Socioeconomic Status
11%
Treatment Refusal
11%
Medicine
9%
Systemic Therapy
9%
Codon
8%
Patient History of Chemotherapy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Fluorouracil
92%
Clinical Trial
74%
Carcinoma
70%
Cisplatin
69%
Amifostine
48%
Filgrastim
44%
Hydroxycarbamide
44%
Recombinant Interferon
44%
Disease
41%
Diarrhea
40%
Phase I Trials
35%
Metastasis
35%
Squamous Cell Carcinoma
31%
Solid Malignant Neoplasm
26%
Uterine Cervix Carcinoma
22%
Sargramostim
22%
Alitretinoin
22%
Colorectal Cancer
22%
Octreotide
22%
Retinoic Acid
22%
Oncolytic Adenovirus
22%
Fluoropyrimidine
22%
Lontucirev
22%
Cancer Recurrence
22%
Pancreas Tumor
22%
Somatostatin Derivative
22%
Stomach Carcinoma
22%
Stomach Tumor
22%
Neuroendocrine Tumor
22%
Pharmacokinetics
22%
Maximum Tolerated Dose
22%
Alpha Interferon
20%
Thymidine Triphosphate
18%
Ribonucleotide Reductase
17%
Myelitis
14%
Adenocarcinoma
14%
Phase II Trials
14%
Esophagus Carcinoma
13%
Colorectal Carcinoma
10%
Malignant Neoplasm
9%
Stomach Cancer
8%
Pancreas Cancer
8%
Thymidylate Synthase
8%
Ototoxicity
8%
Chemotherapy
8%
Recombinant Alpha2b Interferon
7%
Uterine Cervix Cancer
7%
Granulocytopenia
7%
Hypoglycemia
6%
Keyphrases
Cervical Carcinoma
44%
Advanced Carcinoma
37%
Interferon-α (IFN-α)
33%
Gynecologic Oncology Group
29%
New York
29%
External Beam Radiotherapy
27%
5-fluorouracil (5-FU)
24%
Stereotactic Body Radiation Therapy
22%
Sargramostim
22%
Group Studies
22%
Thymidine Phosphorylase
22%
Platelet-derived Endothelial Cell Growth Factor
22%
Hyperfractionated
22%
External Radiation Therapy
22%
Prolonged Infusion
22%
Locally Advanced
22%
Radiation Therapy
22%
Academic Cancer Center
22%
Phase II Clinical Study
22%
Stereotactic Body Radiotherapy
22%
WR-2721
22%
Ras2
22%
Cisplatin
22%
Audiological Outcome
22%
Oncolytic Adenovirus
22%
Phase II Study
22%
Intralesional Administration
22%
Invasive Cervical Cancer
22%
Dose-intensive
22%
Advanced Gastric Carcinoma
22%
9-cis Retinoic Acid
22%
Esophageal Squamous Cell Carcinoma
22%
Recombinant Interferon
22%
Pharmacokinetic Study
22%
Head-and-neck Cancer
22%
Plasma Parameters
22%
Pharmacokinetic Parameters
14%
Radiation Myelopathy
14%
Retinoic
14%
Parent Compounds
14%
Retinoids
14%
Response Rate
12%
Re-irradiation
11%
Compliance Behavior
11%
Acceleration Radiation
11%
Predictors of Non-compliance
11%
Patient Compliance
11%
Squamous Cell
10%
Stage II-III
9%
Metastatic Esophageal Carcinoma
8%